FM
Family Management Portfolio holdings
AUM
$658M
This Quarter Return
+0.29%
1 Year Return
+14.42%
3 Year Return
+54.25%
5 Year Return
+91.79%
10 Year Return
+224.62%
AUM
$145M
AUM Growth
+$145M
(+0.11%)
Cap. Flow
+$723K
Cap. Flow
% of AUM
0.5%
Top 10 Holdings %
Top 10 Hldgs %
43.81%
Holding
80
New
10
Increased
29
Reduced
16
Closed
10
Top Buys
| 1 |
Amgen
AMGN
|
$4.09M |
| 2 |
Walt Disney
DIS
|
$3.45M |
| 3 |
Citigroup
C
|
$3.23M |
| 4 |
Procter & Gamble
PG
|
$2.77M |
| 5 |
Kraft Heinz
KHC
|
$2.7M |
Top Sells
| 1 |
Starbucks
SBUX
|
$4.27M |
| 2 |
Waste Management
WM
|
$3.28M |
| 3 |
AGN
Allergan plc
AGN
|
$2.78M |
| 4 |
Comcast
CMCSA
|
$2.06M |
| 5 |
Apple
AAPL
|
$1.9M |
Sector Composition
| 1 | Technology | 20.89% |
| 2 | Financials | 17.05% |
| 3 | Healthcare | 13.22% |
| 4 | Communication Services | 12.05% |
| 5 | Consumer Staples | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Kraft Heinz
KHC
$31.9B
| $2.7M | 1.86% |
+31,525
| New | +$2.7M |
|
27
Truist Financial
TFC
$59.8B
| $2.43M | 1.67% |
53,418
+9,080
| +20% | +$412K |
|
28
Meta Platforms (Facebook)
META
$1.85T
| $1.64M | 1.12% |
10,832
+3,645
| +51% | +$550K |
|
29
Bristol-Myers Squibb
BMY
$96.7B
| $1.18M | 0.81% |
21,155
+10,700
| +102% | +$596K |
|
|
RPT
30
Rithm Property Trust Inc.
RPT
$118M
| $1.06M | 0.73% |
75,602
+37,623
| +99% | +$526K |
|
31
Berkshire Hathaway Class A
BRK.A
$1.08T
| $1.02M | 0.7% |
4
+1
| +33% | +$255K |
|
32
Acadia Pharmaceuticals
ACAD
$4.34B
| $990K | 0.68% |
35,500
| – | – |
|
|
33
Berkshire Hathaway Class B
BRK.B
$1.08T
| $761K | 0.52% |
4,493
+450
| +11% | +$76.2K |
|
|
AGN
34
DELISTED
Allergan plc
AGN
| $557K | 0.38% |
2,290
-11,433
| -83% | -$2.78M |
|
35
Philip Morris
PM
$254B
| $551K | 0.38% |
4,692
+1,500
| +47% | +$176K |
|
|
NYMTO
36
DELISTED
New York Mortgage Trust, Inc. 7.875% Series C Cumulative Redeemable Preferred Stock
NYMTO
| $531K | 0.37% |
21,420
+9,210
| +75% | +$228K |
|
37
Stryker
SYK
$149B
| $500K | 0.34% |
3,600
| – | – |
|
38
DigitalBridge
DBRG
$2.05B
| $475K | 0.33% |
33,686
+15,205
| +82% | +$214K |
|
39
Lineage Cell Therapeutics
LCTX
$281M
| $442K | 0.3% |
140,371
+2,000
| +1% | +$6.3K |
|
40
Chevron
CVX
$318B
| $419K | 0.29% |
4,020
| – | – |
|
41
Target
TGT
$42B
| $418K | 0.29% |
+8,000
| New | +$418K |
|
42
Pfizer
PFE
$141B
| $354K | 0.24% |
10,550
+2,550
| +32% | +$85.6K |
|
43
Enterprise Products Partners
EPD
$68.9B
| $340K | 0.23% |
12,572
-575
| -4% | -$15.6K |
|
44
AT&T
T
$208B
| $337K | 0.23% |
8,921
-1,027
| -10% | -$38.8K |
|
45
Merck
MRK
$210B
| $329K | 0.23% |
5,136
| – | – |
|
46
Altria Group
MO
$112B
| $299K | 0.21% |
4,012
-1,996
| -33% | -$149K |
|
47
Alphabet (Google) Class C
GOOG
$2.79T
| $288K | 0.2% |
317
+29
| +10% | +$26.3K |
|
48
JPMorgan Chase
JPM
$824B
| $281K | 0.19% |
+3,079
| New | +$281K |
|
49
Energy Transfer Partners
ET
$60.3B
| $251K | 0.17% |
14,000
| – | – |
|
50
Teva Pharmaceuticals
TEVA
$21.5B
| $241K | 0.17% |
7,250
| – | – |
|